Winner PED-Blue Mario Kart promotion during IRPA The Hague!

Winner PED-Blue Mario Kart promotion

Bart Vermolen, working at Ziekenhuis Gelderse Vallei and owner of Vermolen Advies in Klinische Fysica, is the winner of the PED-lottery amongst the twenty fastest times of the Mario Kart promotion during the IRPA, June 4-9. The Personal Electronic Dosimeter is in good hands with a medical physicist:“As a medical physicist, I am the medical support specialist within the healthcare department that can monitor the safety, quality and efficiency of medical technology in the healthcare facility. From my technical background I do this at the level of the medical specialist, where the objective, the best care for the patient, is never lost sight of. The added value of the medical physicist therefore lies in the two-way approach. “

Vermolen Advies in Klinische Fysica advises healthcare institutions in the field of medical technology and radiation applications. Not only hospitals belong to the interested parties, clinics and dentists also use the services.For a support specialist focused on the safety and quality of medical technology, the PED-Blue is an indispensable tool for controlling and limiting exposure to radiation. The personal dosimeters from the Tracerco PED family are the most user-friendly in the market. All functions of the devices are designed with the user’s wishes as the starting point. The PED is functional within minutes after the software is put into operation. The PED has a discrete mode (no sound and flashing LEDs on alarms), a task function in which the start and stop of a task can be recorded and be seen again thanks to the supplied DoseVision software. Because of this software, any measurement from the past can be retrieved. It’s ideal for organizations with a focus on the ALARA-principle.

PED-Blue measurements during a flight

Would you like to know more about the PED-Blue or other PEDs of the Tracerco PED family?
Click on the button below to download the brochure.

Would you like to be kept informed of developments in your field?
Subscribe for the newsletter.